268 related articles for article (PubMed ID: 28212543)
1. Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.
Pereira MSL; Klamt F; Thomé CC; Worm PV; de Oliveira DL
Oncotarget; 2017 Mar; 8(13):22279-22298. PubMed ID: 28212543
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Zhang C; Yuan XR; Li HY; Zhao ZJ; Liao YW; Wang XY; Su J; Sang SS; Liu Q
Cell Physiol Biochem; 2015; 35(2):419-32. PubMed ID: 25613036
[TBL] [Abstract][Full Text] [Related]
3. Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.
Ciceroni C; Bonelli M; Mastrantoni E; Niccolini C; Laurenza M; Larocca LM; Pallini R; Traficante A; Spinsanti P; Ricci-Vitiani L; Arcella A; De Maria R; Nicoletti F; Battaglia G; Melchiorri D
Cell Death Differ; 2013 Mar; 20(3):396-407. PubMed ID: 23175182
[TBL] [Abstract][Full Text] [Related]
4. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between BDNF and mGluR II in vitro: BDNF down-regulated mGluR II gene expression and an mGluR II agonist enhanced BDNF-induced BDNF gene expression in rat cerebral cortical neurons.
Suzuki S; Koshimizu H; Adachi N; Matsuoka H; Fushimi S; Ono J; Ohta KI; Miki T
Peptides; 2017 Mar; 89():42-49. PubMed ID: 28119091
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.
Maier JP; Ravi VM; Kueckelhaus J; Behringer SP; Garrelfs N; Will P; Sun N; von Ehr J; Goeldner JM; Pfeifer D; Follo M; Hannibal L; Walch AK; Hofmann UG; Beck J; Heiland DH; Schnell O; Joseph K
Cell Death Dis; 2021 Jul; 12(8):723. PubMed ID: 34290229
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
[TBL] [Abstract][Full Text] [Related]
8. The Role of Metabotropic Glutamate Receptor 1 Dependent Signaling in Glioma Viability.
Dalley CB; Wroblewska B; Wolfe BB; Wroblewski JT
J Pharmacol Exp Ther; 2018 Oct; 367(1):59-70. PubMed ID: 30054311
[TBL] [Abstract][Full Text] [Related]
9. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
Lea PM; Wroblewska B; Sarvey JM; Neale JH
J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
[TBL] [Abstract][Full Text] [Related]
10. Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.
Iacovelli L; Orlando R; Rossi A; Spinsanti P; Melchiorri D; Nicoletti F
Curr Opin Pharmacol; 2018 Feb; 38():59-64. PubMed ID: 29525720
[TBL] [Abstract][Full Text] [Related]
11. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors.
Kawashima N; Karasawa J; Shimazaki T; Chaki S; Okuyama S; Yasuhara A; Nakazato A
Neurosci Lett; 2005 Apr; 378(3):131-4. PubMed ID: 15781145
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor ligands as potential therapeutics for addiction.
Olive MF
Curr Drug Abuse Rev; 2009 Jan; 2(1):83-98. PubMed ID: 19630739
[TBL] [Abstract][Full Text] [Related]
13. Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
Ciceroni C; Arcella A; Mosillo P; Battaglia G; Mastrantoni E; Oliva MA; Carpinelli G; Santoro F; Sale P; Ricci-Vitiani L; De Maria R; Pallini R; Giangaspero F; Nicoletti F; Melchiorri D
Neuropharmacology; 2008 Sep; 55(4):568-76. PubMed ID: 18621067
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas.
Condorelli DF; Dell'Albani P; Corsaro M; Giuffrida R; Caruso A; Trovato Salinaro A; Spinella F; Nicoletti F; Albanese V; Giuffrida Stella AM
Neurochem Res; 1997 Sep; 22(9):1127-33. PubMed ID: 9251103
[TBL] [Abstract][Full Text] [Related]
15. The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia.
Harrison PJ; Lyon L; Sartorius LJ; Burnet PW; Lane TA
J Psychopharmacol; 2008 May; 22(3):308-22. PubMed ID: 18541626
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins.
Aronica E; Gorter JA; Ijlst-Keizers H; Rozemuller AJ; Yankaya B; Leenstra S; Troost D
Eur J Neurosci; 2003 May; 17(10):2106-18. PubMed ID: 12786977
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Group I Metabotropic Glutamate Receptors Reverses Autistic-Like Phenotypes Caused by Deficiency of the Translation Repressor eIF4E Binding Protein 2.
Aguilar-Valles A; Matta-Camacho E; Khoutorsky A; Gkogkas C; Nader K; Lacaille JC; Sonenberg N
J Neurosci; 2015 Aug; 35(31):11125-32. PubMed ID: 26245973
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for malignant gliomas: an update].
Wakabayashi T; Natsume A; Fujii M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1283-7. PubMed ID: 24105052
[TBL] [Abstract][Full Text] [Related]
20. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
